Antibody Engineering & Therapeutics

Where Antibody, Protein and ADC Innovation is Driven to Commercial Success
USA's Leading Antibody Event for Discovery, Engineering and Therapeutic Development in Neurodegeneration, Metabolism, Autoimmunity & Much More.

Let’s turn conversations into opportunities! Meet us at Booth #209

During the conference, our experts will share valuable insights through one scientific briefing. Explore the details below and be sure not to miss this opportunity!

Date: Tuesday, December 15
Time: 12:35 - 1:05 pm
Title: Evolution of Specifica’s Gen3 technology: functional bispecifics directly from constant light chain libraries
Speakers:
Andrew Bradbury, CSO at Specifica, an IQVIA Business
Christina Pettus, Associate Director, Project Services at Specifica, an IQVIA Business